Summary Objectives As first line therapy, pembrolizumab provides longer progression free survival (PFS) and overall survival (OS) than platinum doublets in programmed death ligand 1 (PD-L1)-positive non-small cell lung cancer (NSCLC) with tumor propensity scores (TPS) ≥50%. However, clinical trials do not represent real-world patients. Materials and Methods This multicenter retrospective study conducted across 11 medical centers in Japan analyzed clinical data from patients receiving...
The authors regret to inform that there were unknowing errors in figures. The corrected images are given below. These figures are not affecting the results and conclusion of the manuscript. Hence, the text in original paper remains unchanged.
Mark above section as read
Therapeutic Hypothermia and Temperature Management, Ahead of Print.
Mark above section as read
Publication date: Available online 6 August 2019Source: Photodiagnosis and Photodynamic TherapyAuthor(s): Sergio Alique-García, Daniel Alique, Jaime Company-Quiroga, Alberto Sánchez, Almudena Hernández Núñez, J. BorbujoAbstractAn observational study was carried out in the photodynamic therapy (PDT) section of Fuenlabrada’s hospital (Madrid, Spain). Our goal was to investigate the efficacy and safety of PDT in Bowen’s disease (BD). Between June 2011-June 2017 171 patients (191 lesions) with diagnosis...
Publication date: Available online 6 August 2019Source: Photodiagnosis and Photodynamic TherapyAuthor(s): Na-Ri Shin, Yeo-Jin Yi, Jun-Seon ChoiAbstractBackgroundThe Quantitative Light-induced Fluorescence-Digital (QLF-D) system visualizes old and mature dental biofilm as red fluorescence. Risk factors for poor oral hygiene have been identified, however, few studies have evaluated the relationship between mature dental biofilm and hand motor functions. This study aimed to investigate the effects of...
Mark above section as read
Publication date: October 2019Source: Biomedicine & Pharmacotherapy, Volume 118Author(s): Nadine Pinder, Johannes B. Zimmermann, Silke Gastine, Gudrun Würthwein, Georg Hempel, Thomas Bruckner, Torsten Hoppe-Tichy, Markus A. Weigand, Stefanie SwobodaAbstractBackgroundIn the context of the cholinergic anti-inflammatory pathway, the clinical trial Anticholium® per Se (EudraCT Number: 2012-001650-26, ClinicalTrials.gov NCT03013322) addressed the possibility of taking adjunctive physostigmine salicylate...
Mark above section as read
Publication date: October 2019Source: International Immunopharmacology, Volume 75Author(s): Pibao Li, Yanfen Yao, Yuezhen Ma, Yanbin ChenAbstractAcute lung injury (ALI) and its severe manifestation of acute respiratory distress syndrome (ARDS) in human lung are induced by inflammatory cytokines and endogenous factors such as miRNAs. However, the role of miR-150 in lipopolysaccharide (LPS)-induced ALI is not clear. Here, we found miR-150 expression was significantly reduced in the serum of patients...
Mark above section as read
Tissue Engineering Part A, Volume 25, Issue 15-16, Page 1146-1154, August 2019.
Tissue Engineering Part A, Volume 25, Issue 15-16, Page 1189-1189, August 2019.
Tissue Engineering Part A, Volume 25, Issue 15-16, Page 1167-1174, August 2019.
Tissue Engineering Part A, Volume 25, Issue 15-16, Page 1188-1188, August 2019.
Tissue Engineering Part A, Volume 25, Issue 15-16, Page 1190-1190, August 2019.
Tissue Engineering Part A, Volume 25, Issue 15-16, Page 1067-1071, August 2019.
Mark above section as read
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου